178 related articles for article (PubMed ID: 6415164)
21. Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells.
Männel DN; Farrar JJ; Mergenhagen SE
J Immunol; 1980 Mar; 124(3):1106-10. PubMed ID: 6987307
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
Lee KC; La Posta VJ
J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
[TBL] [Abstract][Full Text] [Related]
23. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
24. Suppression of ACTH-induced steroidogenesis by supernatants from LPS-treated peritoneal exudate macrophages.
Mathison JC; Schreiber RD; La Forest AC; Ulevitch RJ
J Immunol; 1983 Jun; 130(6):2757-62. PubMed ID: 6304189
[TBL] [Abstract][Full Text] [Related]
25. Glucan stimulates production of antitumor cytolytic/cytostatic factor(s) by macrophages.
Sherwood ER; Williams DL; Di Luzio NR
J Biol Response Mod; 1986 Dec; 5(6):504-26. PubMed ID: 3794756
[TBL] [Abstract][Full Text] [Related]
26. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
Farrar WL; Mizel SB; Farrar JJ
J Immunol; 1980 Mar; 124(3):1371-7. PubMed ID: 6153680
[TBL] [Abstract][Full Text] [Related]
27. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
28. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors.
Magez S; Stijlemans B; Radwanska M; Pays E; Ferguson MA; De Baetselier P
J Immunol; 1998 Feb; 160(4):1949-56. PubMed ID: 9469458
[TBL] [Abstract][Full Text] [Related]
29. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
Farram E; Geczy CL; Moon DK; Hopper K
J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
[TBL] [Abstract][Full Text] [Related]
30. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
31. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
33. Macrophages as cytotoxic effector cells.
Lohmann-Matthes ML; Lang H; Sun D
Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
[TBL] [Abstract][Full Text] [Related]
34. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
[TBL] [Abstract][Full Text] [Related]
35. Ca2+-calmodulin regulates the induction and expression of macrophage cytotoxicity.
Nguyen HK; Cain CA; Tompkins WA
J Biol Response Mod; 1987 Apr; 6(2):154-68. PubMed ID: 3585411
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate.
Gemsa D; Staar U; Grimm W; Hausmann G; Körner CF; Resch K; Krammer PH
IARC Sci Publ; 1984; (56):319-36. PubMed ID: 6085623
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the activity of sea bass (Dicentrarchus labrax) head-kidney macrophages by macrophage activating factor(s) and lipopolysaccharide.
Sarmento A; Marques F; Ellis AE; Afonso A
Fish Shellfish Immunol; 2004 Feb; 16(2):79-92. PubMed ID: 15123313
[TBL] [Abstract][Full Text] [Related]
38. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
39. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
40. Molecular weight, isoelectric point, and stability of a murine lymphokine that induces macrophage tumoricidal activity.
Yamamoto S; Leonard EJ; Meltzer M
J Reticuloendothel Soc; 1983 May; 33(5):343-51. PubMed ID: 6341579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
